1,2-dimethylhydrazine increases expression ISO RGD:1614461 6480464 1, 2-Dimethylhydrazine results in increased expression of FOXC2 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1347315 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of FOXC2 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1614461 6480464 Tetrachlorodibenzodioxin results in increased expression of FOXC2 mRNA CTD PMID:24058054 , PMID:26139165 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1614461 6480464 Tetrachlorodibenzodioxin results in decreased expression of FOXC2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1614461 6480464 Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to FOXC2 promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1614461 6480464 Tetrachlorodibenzodioxin affects the expression of FOXC2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1347315 6480464 Tetrachlorodibenzodioxin results in decreased expression of FOXC2 mRNA CTD PMID:21296121 2-hydroxypropanoic acid decreases expression ISO RGD:1347315 6480464 Lactic Acid results in decreased expression of FOXC2 mRNA CTD PMID:30851411 4,4'-sulfonyldiphenol increases expression ISO RGD:1614461 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FOXC2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases methylation ISO RGD:1614461 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of FOXC2 exon CTD PMID:33297965 5-aza-2'-deoxycytidine increases expression ISO RGD:1614461 6480464 Decitabine results in increased expression of FOXC2 mRNA CTD PMID:27915011 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FOXC2 mRNA CTD PMID:24780913 abacavir decreases expression ISO RGD:1347315 6480464 abacavir results in decreased expression of FOXC2 mRNA CTD PMID:31711903 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of FOXC2 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:1347315 6480464 Aflatoxin B1 results in decreased methylation of FOXC2 gene CTD PMID:27153756 aldrin increases expression ISO RGD:1614461 6480464 Aldrin results in increased expression of FOXC2 mRNA CTD PMID:18579281 all-trans-retinoic acid increases expression ISO RGD:1347315 6480464 Tretinoin results in increased expression of FOXC2 mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:1347315 6480464 Tretinoin inhibits the reaction [[Chir 99021 co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC2 mRNA] CTD PMID:31711903 all-trans-retinoic acid decreases expression ISO RGD:1347315 6480464 Tretinoin results in decreased expression of FOXC2 mRNA CTD PMID:31711903 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FOXC2 mRNA CTD PMID:16483693 arsenite(3-) increases methylation ISO RGD:1347315 6480464 arsenite results in increased methylation of FOXC2 promoter CTD PMID:23974009 belinostat increases expression ISO RGD:1347315 6480464 belinostat results in increased expression of FOXC2 mRNA CTD PMID:26272509 benzo[a]pyrene multiple interactions ISO RGD:1614461 6480464 Benzo(a)pyrene affects the reaction [AHR protein binds to FOXC2 promoter] CTD PMID:19654925 benzo[a]pyrene decreases methylation ISO RGD:1347315 6480464 Benzo(a)pyrene results in decreased methylation of FOXC2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1347315 6480464 Benzo(a)pyrene affects the methylation of FOXC2 exon CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1614461 6480464 Benzo(a)pyrene results in increased expression of FOXC2 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1347315 6480464 7 more ... CTD PMID:20382639 bisphenol A affects methylation ISO RGD:1614461 6480464 bisphenol A affects the methylation of FOXC2 promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FOXC2 mRNA CTD PMID:29323181 bisphenol A increases expression ISO RGD:1614461 6480464 bisphenol A results in increased expression of FOXC2 mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FOXC2 mRNA CTD PMID:30816183 more ... bisphenol F increases expression ISO RGD:1614461 6480464 bisphenol F results in increased expression of FOXC2 mRNA CTD PMID:30951980 bisphenol F decreases expression ISO RGD:1614461 6480464 bisphenol F results in decreased expression of FOXC2 mRNA CTD PMID:36706583 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of FOXC2 mRNA CTD PMID:19167457 cannabidiol increases expression ISO RGD:1347315 6480464 Cannabidiol results in increased expression of FOXC2 mRNA CTD PMID:27918106 CHIR 99021 multiple interactions ISO RGD:1347315 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 more ... CTD PMID:31711903 choline multiple interactions ISO RGD:1614461 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FOXC2 gene CTD PMID:20938992 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of FOXC2 mRNA CTD PMID:17898221 dabigatran decreases expression ISO RGD:1347315 6480464 Dabigatran results in decreased expression of FOXC2 mRNA CTD PMID:31711903 DDE increases activity ISO RGD:1347315 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of FOXC2 protein CTD PMID:27589886 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of FOXC2 mRNA CTD PMID:23914054 diallyl disulfide multiple interactions ISO RGD:1347315 6480464 diallyl disulfide inhibits the reaction [tobacco tar analog results in decreased expression of FOXC2 mRNA] CTD PMID:36758788 dimethylselenide multiple interactions ISO RGD:1347315 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA, [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA CTD PMID:33656867 dioxygen increases expression ISO RGD:1614461 6480464 Oxygen deficiency results in increased expression of FOXC2 mRNA CTD PMID:24205000 dorsomorphin multiple interactions ISO RGD:1347315 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1347315 6480464 Doxorubicin results in decreased expression of FOXC2 mRNA CTD PMID:29803840 Doxylamine succinate decreases expression ISO RGD:1347315 6480464 doxylamine succinate results in decreased expression of FOXC2 mRNA CTD PMID:31711903 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of FOXC2 mRNA CTD PMID:29391264 ethylene glycol decreases expression ISO RGD:1347315 6480464 Ethylene Glycol results in decreased expression of FOXC2 mRNA CTD PMID:31711903 folic acid multiple interactions ISO RGD:1614461 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FOXC2 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:1614461 6480464 Folic Acid results in decreased expression of FOXC2 mRNA CTD PMID:25629700 genistein increases expression ISO RGD:1614461 6480464 Genistein results in increased expression of FOXC2 mRNA CTD PMID:32186404 hydrazines decreases expression ISO RGD:1614461 6480464 Hydrazines results in decreased expression of FOXC2 mRNA CTD PMID:21647536 hydroxyl multiple interactions ISO RGD:1347315 6480464 [[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA CTD PMID:33656867 isotretinoin decreases expression ISO RGD:1347315 6480464 Isotretinoin results in decreased expression of FOXC2 mRNA CTD PMID:31711903 L-methionine multiple interactions ISO RGD:1614461 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FOXC2 gene CTD PMID:20938992 mercury dibromide multiple interactions ISO RGD:1347315 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC2 mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO RGD:1347315 6480464 methylmercuric chloride results in increased expression of FOXC2 mRNA CTD PMID:28001369 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FOXC2 mRNA CTD PMID:20360939 nickel sulfate increases expression ISO RGD:1614461 6480464 nickel sulfate results in increased expression of FOXC2 mRNA CTD PMID:16100012 nilotinib decreases expression ISO RGD:1347315 6480464 nilotinib results in decreased expression of FOXC2 mRNA CTD PMID:31711903 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of FOXC2 mRNA CTD PMID:33484710 ozone multiple interactions ISO RGD:1347315 6480464 [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of FOXC2-AS1 mRNA] which results in decreased expression of FOXC2 mRNA CTD PMID:33656867 panobinostat increases expression ISO RGD:1347315 6480464 panobinostat results in increased expression of FOXC2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1347315 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC2 mRNA CTD PMID:27188386 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of FOXC2 mRNA CTD PMID:20360939 phenylmercury acetate increases expression ISO RGD:1347315 6480464 Phenylmercuric Acetate results in increased expression of FOXC2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1347315 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC2 mRNA CTD PMID:27188386 phenytoin decreases expression ISO RGD:1347315 6480464 Phenytoin results in decreased expression of FOXC2 mRNA CTD PMID:31711903 pirinixic acid increases expression ISO RGD:1614461 6480464 pirinixic acid results in increased expression of FOXC2 mRNA CTD PMID:20813756 rac-lactic acid decreases expression ISO RGD:1347315 6480464 Lactic Acid results in decreased expression of FOXC2 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1614461 6480464 [Dietary Fats co-treated with Resveratrol] results in increased expression of FOXC2 mRNA CTD PMID:29197120 SB 431542 multiple interactions ISO RGD:1347315 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:31711903 sulforaphane decreases expression ISO RGD:1347315 6480464 sulforaphane results in decreased expression of FOXC2 mRNA CTD PMID:31838189 thalidomide decreases expression ISO RGD:1347315 6480464 Thalidomide results in decreased expression of FOXC2 mRNA CTD PMID:31711903 trichostatin A increases expression ISO RGD:1347315 6480464 trichostatin A results in increased expression of FOXC2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1347315 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FOXC2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1614461 6480464 Valproic Acid results in increased expression of FOXC2 mRNA CTD PMID:19136453 , PMID:21427059 valproic acid increases expression ISO RGD:1347315 6480464 Valproic Acid results in increased expression of FOXC2 mRNA CTD PMID:23179753 valproic acid decreases expression ISO RGD:1347315 6480464 Valproic Acid results in decreased expression of FOXC2 mRNA CTD PMID:31711903